Adjuvant chemotherapy for resected early-stage non-small cell lung cancer.

Burdett, Sarah; Pierre Pignon, Jean; Tierney, Jayne; Tribodet, Helene; Stewart, Lesley; Le Pechoux, Cecile; Aupérin, Anne; Le Chevalier, Thierry; J Stephens, Richard; Arriagada, Rodrigo; P T Higgins, Julian; H Johnson, David; Van Meerbeeck, Jan; K B Parmar, Mahesh; L Souhami, Robert; Bergman, Bengt; Douillard, Jean-Yves; Dunant, Ariane; Endo, Chiaki; Girling, David; Kato, Harubumi; M Keller, Steven; Kimura, Hideki; Knuuttila, Aija; Kodama, Ken; Komaki, Ritsuko; G Kris, Mark; Lad, Thomas; Mineo, Tommaso; Piantadosi, Steven; Rosell, Rafael; Scagliotti, Giorgio; K Seymour, Lesley; A Shepherd, Frances; Sylvester, Richard; Tada, Hirohito; Tanaka, Fumihiro; Torri, Valter; Waller, David; Liang, Ying; Cell Lung Cancer Collaborative Group, Non‐Small

doi:10.1002/14651858.CD011430

Public

Adjuvant chemotherapy for resected early-stage non-small cell lung cancer.

Shared by NobleBlocks on Mar 2, 2015 • 12:00 AM UTC

Authors:

Sarah Burdett

Jean Pierre Pignon

Jayne Tierney

Abstract

BACKGROUND: To evaluate the effects of administering chemotherapy following surgery, or following surgery plus radiotherapy (known as adjuvant chemotherapy) in patients with early stage non-small cell lung cancer (NSCLC),we performed two systematic reviews and meta-analyses of all randomised control...

Discussions